Bayer Sexual Function Award
The American Foundation for Urologic Disease (AFUD) and Bayer has announced that Daniel DeNoon, an online journalist, and former NewsRx reporter, is the recipient of the first “Bayer Excellence in Sexual Function Writing” award. This award represents a partnership between AFUD and Bayer for the purposes of raising awareness of sexual dysfunction and educating patients and their partners on available options.
Sexual dysfunction has often been the brunt of late night talk show jokes; furthering the public’s misunderstanding that it is a lifestyle problem and not a serious medical condition. It is estimated that more than 140 million men worldwide suffer from some form of erectile dysfunction, and female sexual dysfunction affects more than 9.7 million women. Bayer’s award not only raises awareness, but encourages a professional and medical approach in sexual function journalism.
“As we improve our therapies for male and female sexual dysfunction, so too must we improve our ability to discuss these subjects with our healthcare providers. Articles such as these are a first step in breaking down the barriers to healthy communication on these important matters,” said John Mulcahy, cochairman of AFUD’s Sexual Function Health Council.
Health care writers from across the country were invited to submit their best, consumer-focused articles on male or female sexual function. DeNoon’s article was selected by a panel of judges comprising representatives of both the health care and journalism professionals. The judges evaluated the submissions based on the accuracy of medical facts, the balance of various sexual dysfunction therapies, and the journalistic appeal.
He will receive a cash prize and will be recognized during National Sexual Health Month. National Sexual Health Month, celebrated in September and established by the AFUD’s Sexual Function Health Council, seeks to raise awareness of sexual dysfunction and available treatment options.
The winning article was entitled, “You’ve Got Prostate Cancer.” The article discusses the various treatment options available for prostate cancer and the effect each treatment has on sexual function.
“This contest, like all journalism contests, like it or not, gets journalists to dig deeper, use more sources, and writer better. It also raises the bar on professional and factual reporting of medical content,” said Don Ranly, panelist and professor of journalism at the University of Missouri in Columbia.
Two other award finalists, Shari Roan, a print journalist, and Lorraine Bennett, an online journalist, also have been recognized for their talent in journalism and professional reporting of sexual function.